Ketamine-Induced Uropathy: Emerging Challenges and Effective Interventions

Ketamine‑Induced Uropathy: Emerging Challenges and Effective Interventions A study day for healthcare professionals Addressing the UK’s fastest‑growing bladder health crisis Ketamine‑induced uropathy (KIU) has rapidly become one of the most urgent and complex bladder health challenges facing clinicians across the UK. With cases rising sharply among young people and frontline services under increasing pressure, our Bladder Health UK study day brings together leading experts in urology, addiction psychiatry, pelvic health, psychology and primary care to share the latest evidence, best practice, and real‑world clinical insights. This one‑day event is designed to equip healthcare professionals with the knowledge, confidence and practical tools needed to recognise, assess and support patients living with ketamine‑related bladder harm. Through a mix of keynote talks, clinical updates, multidisciplinary discussion and specialist-led sessions, delegates will gain a deeper understanding of the condition and the pathways that can improve patient outcomes. Who Should Attend This study day is ideal for: • Urologists & urology nurses • GPs & primary care teams • Addiction specialists & mental health professionals • Pelvic health physiotherapists • Pain management clinicians • Emergency department staff • Allied health professionals • Anyone supporting patients affected by ketamine‑related bladder symptoms This study day provides 7 hours of CPD‑relevant learning. What You Will Learn Delegates will leave with: • A clear understanding of current national ketamine use trends and the scale of KIU • Up‑to‑date knowledge on assessment, diagnosis and treatment options • Insight into addiction pathways, harm reduction and recovery support • Practical strategies for managing bladder pain and complex symptoms • Pelvic‑floor‑focused approaches to support long‑term bladder health • A multidisciplinary perspective on supporting patients through recovery and beyond Programme Highlights Featuring sessions from: • Alison Downey – Clinical overview and treatment pathways • Prof Owen Bowden‑Jones CBE – Addiction and harm reduction • Dr Karen Ousey – Professor of Skin Integrity • Louise Fields – Pelvic health recovery strategies • Dr Sally Morrison‑Griffiths – Clinical pathways for patient recovery Why Attend Ketamine‑induced uropathy is no longer a rare presentation, it is a rapidly escalating public health issue. This study day offers a unique opportunity to learn directly from national leaders, share experiences with colleagues and strengthen your clinical approach to a condition that is increasingly appearing across healthcare settings. Together, we can improve recognition, reduce harm and support patients towards better bladder health and recovery. PLACES ARE LIMITED SO BOOK NOW TO AVOID DISSAPOINTMENT Accessibility, venue & travel information Accessibility Friends House is a fully accessible venue. Step‑free access is available throughout the building, with lifts to all floors, accessible toilets, wide corridors and clear signage. Hearing loops are available in the main meeting rooms. If you have any specific access needs, please let us know, Bladder Health UK will do everything we can to support you. Venue Friends House 173–177 Euston Road London NW1 2BJ Located directly opposite Euston Station, the venue is bright, calm and easy to navigate, with plenty of space for breaks and conversation. Travel • By train: Friends House is a 2‑minute walk from Euston Station, and around 10 minutes from King’s Cross St Pancras. • By Underground: Euston (Northern/Victoria lines) and Euston Square (Circle/Metropolitan/Hammersmith & City lines) are both very close. • By bus: Multiple routes stop directly outside the venue on Euston Road. • By car: Limited on‑street parking is available; public car parks are within walking distance. We recommend public transport where possible due to central London traffic. • By mobility taxi: Drop‑off is available directly outside the main entrance.